top of page
Browse by category
Search
Analysis of SCORE and PRIDE studies shows semaglutide results in improved functional outcomes, health-related quality of life and CV events
Analysis of the SCORE and PRIDE studies shows semaglutide results in improved functional outcomes, health-related quality of life and CV...
Expanding access to anti-obesity medications delivers 13% return on investment for society
A USC Schaeffer Center white paper entitled, ‘Lifetime Social Returns From Expanding Access to Anti-Obesity Medication’, finds expanded...
First patient dosed in study of Corbus’ next-generation CB1 Inverse Agonist CRB-913 for the treatment of obesity
The first patient has been dosed in Corbus Pharmaceuticals in the single ascending dose/multiple ascending dose (SAD/MAD) portion of the...
Vivani issues positive preclinical weight loss data for NPM-139 semaglutide implant
Vivani Medical has announced promising preclinical data for NPM-139, its subdermal semaglutide implant under development for chronic...
BMS demonstrates superior efficacy over non-surgical treatments in managing obesity and associated metabolic disorders
A systematic review and meta-analysis of randomised clinical trials (RCTs) underscores the superior efficacy of bariatric and metabolic...
Sucralose alters brain activity related to hunger and increases appetite, especially in people with obesity
A study from the Keck School of Medicine of USC found that sucralose, a common sugar substitute, alters brain activity related to hunger...
Bioequivalence of RT-114, delivered orally via the RaniPill capsule, to subcutaneously administered PG-102
Rani Therapeutics has announced pharmacokinetic and pharmacodynamic data from a preclinical study evaluating RT-114, a GLP-1/GLP-2 dual...
Why obesity takes away the pleasure of eating
A study by scientists at the University of California, Berkeley, suggests that pleasure in eating, even eating junk food, is key to...
Medicare and other insurance should cover obesity drugs
A large majority of older Americans feel that health insurance - including Medicare - should cover anti-obesity medications, according to...
Journal Watch 26/3/2025
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Browse by tag
bottom of page